---
schema_version: "secwatch.filing_event.v1"
accession: "0001552781-23-000269"
form_type: "8-K"
ticker: "SWKHL"
cik: "0001089907"
company_name: "SWK Holdings Corp"
filed_at: "2023-05-11T23:59:59+00:00"
generated_at: "2026-06-15T03:31:09.849565+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# SWK Holdings Q1 net income rises 33% to $4.6M; revenue falls 15% to $9.4M

## Summary
- GAAP net income $4.6M ($0.36 diluted EPS) vs $3.5M ($0.27) YoY; revenue $9.4M down 15.3%.
- Finance receivables segment adjusted non-GAAP net income $7.3M vs $8.4M YoY; gross receivables $248.8M (+32.2%).
- Adopted CECL: $11.8M allowance for credit losses, $9.7M net reduction to accumulated deficit.
- Enteris operating expenses down 45% QoQ to $1.4M; bid on $7M CDMO projects for 2H23 growth.
- Repurchased 28,766 shares in Q1 for $0.5M; book value per share $21.39.

## SEC filing metadata
- accession: 0001552781-23-000269
- form_type: 8-K
- ticker: SWKHL
- cik: 0001089907
- company_name: SWK Holdings Corp
- filed_at: 2023-05-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1089907/000155278123000269/0001552781-23-000269-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1089907/000155278123000269/e231261_swkh-8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001552781-23-000269
- JSON: https://secwatch.observer/filing/0001552781-23-000269.json
- Plain text: https://secwatch.observer/filing/0001552781-23-000269.txt

## Key facts
- Earnings Releases
  SWK Holdings Corp reported first quarter ended March 31, 2023 results: revenue $9.4 million, net income $4.6 million, EPS $0.36 per diluted share.
  - Period: first quarter ended March 31, 2023
  - Revenue: $9.4 million
  - Net income: $4.6 million
  - EPS: $0.36 per diluted share
  - Result: reported results
  source text: For the first quarter 2023, SWK reported total revenue of $9.4 million, a 15.3% decrease compared to $11.1 million for the first quarter 2022. The $1.7 million decrease in revenue for the three months ended March 31, 2023, consisted of a $1.1 million decrease in Finance Receivables segment revenue and a $0.6 million decrease in Pharmaceutical Development segment revenue. The $1.1 million decrease in Finance Receivables segment revenue was primarily due to a $5.3 million decrease in interest, fees and royalties earned on finance receivables that were paid off in 2022, which was partially offset by a $4.4 million increase in interest and fees earned due to funding new and existing loans. Pre-tax net income for the quarter was flat at $4.5 million for the three months ended March 31, 2023, compared to $4.6 million for the same period of the previous year. The slight year-over-year decrease is primarily due to a $1.7 million decrease in consolidated revenue, partially offset by a $1.9 mill
  evidence_url: https://www.sec.gov/Archives/edgar/data/1089907/000155278123000269/0001552781-23-000269-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.